Furthermore, it was shown that in lung adenocarcinoma, IL-17 induces angiogenic factors through stimulating vascular endothelial growth factor (VEGF) which is primordial for vascular development in implantation sites (Huang et al., 2016). Here, VEGFA is linked to lung adenocarcinoma.